1 Market Overview
1.1 Product Overview and Scope of Delivery System for Inhaled Nitric Oxide Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 With Gas Cylinders
1.3.3 Without Gas Cylinders
1.4 Market Analysis by Application
1.4.1 Overview: Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Delivery System for Inhaled Nitric Oxide Therapy Market Size & Forecast
1.5.1 Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity (2018-2029)
1.5.3 Global Delivery System for Inhaled Nitric Oxide Therapy Average Price (2018-2029)
2 Manufacturers Profiles
2.1 VERO Biotech
2.1.1 VERO Biotech Details
2.1.2 VERO Biotech Major Business
2.1.3 VERO Biotech Delivery System for Inhaled Nitric Oxide Therapy Product and Services
2.1.4 VERO Biotech Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 VERO Biotech Recent Developments/Updates
2.2 Linde plc.
2.2.1 Linde plc. Details
2.2.2 Linde plc. Major Business
2.2.3 Linde plc. Delivery System for Inhaled Nitric Oxide Therapy Product and Services
2.2.4 Linde plc. Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Linde plc. Recent Developments/Updates
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Delivery System for Inhaled Nitric Oxide Therapy Product and Services
2.3.4 Mallinckrodt Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Mallinckrodt Recent Developments/Updates
2.4 Air Liquide Healthcare
2.4.1 Air Liquide Healthcare Details
2.4.2 Air Liquide Healthcare Major Business
2.4.3 Air Liquide Healthcare Delivery System for Inhaled Nitric Oxide Therapy Product and Services
2.4.4 Air Liquide Healthcare Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Air Liquide Healthcare Recent Developments/Updates
2.5 NOxBOX
2.5.1 NOxBOX Details
2.5.2 NOxBOX Major Business
2.5.3 NOxBOX Delivery System for Inhaled Nitric Oxide Therapy Product and Services
2.5.4 NOxBOX Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 NOxBOX Recent Developments/Updates
3 Competitive Environment: Delivery System for Inhaled Nitric Oxide Therapy by Manufacturer
3.1 Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Manufacturer (2018-2023)
3.2 Global Delivery System for Inhaled Nitric Oxide Therapy Revenue by Manufacturer (2018-2023)
3.3 Global Delivery System for Inhaled Nitric Oxide Therapy Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Delivery System for Inhaled Nitric Oxide Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Delivery System for Inhaled Nitric Oxide Therapy Manufacturer Market Share in 2022
3.4.2 Top 6 Delivery System for Inhaled Nitric Oxide Therapy Manufacturer Market Share in 2022
3.5 Delivery System for Inhaled Nitric Oxide Therapy Market: Overall Company Footprint Analysis
3.5.1 Delivery System for Inhaled Nitric Oxide Therapy Market: Region Footprint
3.5.2 Delivery System for Inhaled Nitric Oxide Therapy Market: Company Product Type Footprint
3.5.3 Delivery System for Inhaled Nitric Oxide Therapy Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Delivery System for Inhaled Nitric Oxide Therapy Market Size by Region
4.1.1 Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Region (2018-2029)
4.1.2 Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Region (2018-2029)
4.1.3 Global Delivery System for Inhaled Nitric Oxide Therapy Average Price by Region (2018-2029)
4.2 North America Delivery System for Inhaled Nitric Oxide Therapy Consumption Value (2018-2029)
4.3 Europe Delivery System for Inhaled Nitric Oxide Therapy Consumption Value (2018-2029)
4.4 Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Consumption Value (2018-2029)
4.5 South America Delivery System for Inhaled Nitric Oxide Therapy Consumption Value (2018-2029)
4.6 Middle East and Africa Delivery System for Inhaled Nitric Oxide Therapy Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2018-2029)
5.2 Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Type (2018-2029)
5.3 Global Delivery System for Inhaled Nitric Oxide Therapy Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2018-2029)
6.2 Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Application (2018-2029)
6.3 Global Delivery System for Inhaled Nitric Oxide Therapy Average Price by Application (2018-2029)
7 North America
7.1 North America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2018-2029)
7.2 North America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2018-2029)
7.3 North America Delivery System for Inhaled Nitric Oxide Therapy Market Size by Country
7.3.1 North America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Country (2018-2029)
7.3.2 North America Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2018-2029)
8.2 Europe Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2018-2029)
8.3 Europe Delivery System for Inhaled Nitric Oxide Therapy Market Size by Country
8.3.1 Europe Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Country (2018-2029)
8.3.2 Europe Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Market Size by Region
9.3.1 Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2018-2029)
10.2 South America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2018-2029)
10.3 South America Delivery System for Inhaled Nitric Oxide Therapy Market Size by Country
10.3.1 South America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Country (2018-2029)
10.3.2 South America Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Market Size by Country
11.3.1 Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Delivery System for Inhaled Nitric Oxide Therapy Market Drivers
12.2 Delivery System for Inhaled Nitric Oxide Therapy Market Restraints
12.3 Delivery System for Inhaled Nitric Oxide Therapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Delivery System for Inhaled Nitric Oxide Therapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of Delivery System for Inhaled Nitric Oxide Therapy
13.3 Delivery System for Inhaled Nitric Oxide Therapy Production Process
13.4 Delivery System for Inhaled Nitric Oxide Therapy Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Delivery System for Inhaled Nitric Oxide Therapy Typical Distributors
14.3 Delivery System for Inhaled Nitric Oxide Therapy Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. VERO Biotech Basic Information, Manufacturing Base and Competitors
Table 4. VERO Biotech Major Business
Table 5. VERO Biotech Delivery System for Inhaled Nitric Oxide Therapy Product and Services
Table 6. VERO Biotech Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. VERO Biotech Recent Developments/Updates
Table 8. Linde plc. Basic Information, Manufacturing Base and Competitors
Table 9. Linde plc. Major Business
Table 10. Linde plc. Delivery System for Inhaled Nitric Oxide Therapy Product and Services
Table 11. Linde plc. Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Linde plc. Recent Developments/Updates
Table 13. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 14. Mallinckrodt Major Business
Table 15. Mallinckrodt Delivery System for Inhaled Nitric Oxide Therapy Product and Services
Table 16. Mallinckrodt Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Mallinckrodt Recent Developments/Updates
Table 18. Air Liquide Healthcare Basic Information, Manufacturing Base and Competitors
Table 19. Air Liquide Healthcare Major Business
Table 20. Air Liquide Healthcare Delivery System for Inhaled Nitric Oxide Therapy Product and Services
Table 21. Air Liquide Healthcare Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Air Liquide Healthcare Recent Developments/Updates
Table 23. NOxBOX Basic Information, Manufacturing Base and Competitors
Table 24. NOxBOX Major Business
Table 25. NOxBOX Delivery System for Inhaled Nitric Oxide Therapy Product and Services
Table 26. NOxBOX Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. NOxBOX Recent Developments/Updates
Table 28. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 29. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue by Manufacturer (2018-2023) & (USD Million)
Table 30. Global Delivery System for Inhaled Nitric Oxide Therapy Average Price by Manufacturer (2018-2023) & (K US$/Unit)
Table 31. Market Position of Manufacturers in Delivery System for Inhaled Nitric Oxide Therapy, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 32. Head Office and Delivery System for Inhaled Nitric Oxide Therapy Production Site of Key Manufacturer
Table 33. Delivery System for Inhaled Nitric Oxide Therapy Market: Company Product Type Footprint
Table 34. Delivery System for Inhaled Nitric Oxide Therapy Market: Company Product Application Footprint
Table 35. Delivery System for Inhaled Nitric Oxide Therapy New Market Entrants and Barriers to Market Entry
Table 36. Delivery System for Inhaled Nitric Oxide Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Region (2018-2023) & (Units)
Table 38. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Region (2024-2029) & (Units)
Table 39. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 40. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 41. Global Delivery System for Inhaled Nitric Oxide Therapy Average Price by Region (2018-2023) & (K US$/Unit)
Table 42. Global Delivery System for Inhaled Nitric Oxide Therapy Average Price by Region (2024-2029) & (K US$/Unit)
Table 43. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2018-2023) & (Units)
Table 44. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2024-2029) & (Units)
Table 45. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 46. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 47. Global Delivery System for Inhaled Nitric Oxide Therapy Average Price by Type (2018-2023) & (K US$/Unit)
Table 48. Global Delivery System for Inhaled Nitric Oxide Therapy Average Price by Type (2024-2029) & (K US$/Unit)
Table 49. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2018-2023) & (Units)
Table 50. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2024-2029) & (Units)
Table 51. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 52. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 53. Global Delivery System for Inhaled Nitric Oxide Therapy Average Price by Application (2018-2023) & (K US$/Unit)
Table 54. Global Delivery System for Inhaled Nitric Oxide Therapy Average Price by Application (2024-2029) & (K US$/Unit)
Table 55. North America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2018-2023) & (Units)
Table 56. North America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2024-2029) & (Units)
Table 57. North America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2018-2023) & (Units)
Table 58. North America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2024-2029) & (Units)
Table 59. North America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Country (2018-2023) & (Units)
Table 60. North America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Country (2024-2029) & (Units)
Table 61. North America Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 62. North America Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 63. Europe Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2018-2023) & (Units)
Table 64. Europe Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2024-2029) & (Units)
Table 65. Europe Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2018-2023) & (Units)
Table 66. Europe Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2024-2029) & (Units)
Table 67. Europe Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Country (2018-2023) & (Units)
Table 68. Europe Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Country (2024-2029) & (Units)
Table 69. Europe Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2018-2023) & (Units)
Table 72. Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2024-2029) & (Units)
Table 73. Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2018-2023) & (Units)
Table 74. Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2024-2029) & (Units)
Table 75. Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Region (2018-2023) & (Units)
Table 76. Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Region (2024-2029) & (Units)
Table 77. Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 78. Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 79. South America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2018-2023) & (Units)
Table 80. South America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2024-2029) & (Units)
Table 81. South America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2018-2023) & (Units)
Table 82. South America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2024-2029) & (Units)
Table 83. South America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Country (2018-2023) & (Units)
Table 84. South America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Country (2024-2029) & (Units)
Table 85. South America Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 86. South America Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 87. Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2018-2023) & (Units)
Table 88. Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Type (2024-2029) & (Units)
Table 89. Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2018-2023) & (Units)
Table 90. Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Application (2024-2029) & (Units)
Table 91. Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Region (2018-2023) & (Units)
Table 92. Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity by Region (2024-2029) & (Units)
Table 93. Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 94. Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 95. Delivery System for Inhaled Nitric Oxide Therapy Raw Material
Table 96. Key Manufacturers of Delivery System for Inhaled Nitric Oxide Therapy Raw Materials
Table 97. Delivery System for Inhaled Nitric Oxide Therapy Typical Distributors
Table 98. Delivery System for Inhaled Nitric Oxide Therapy Typical Customers
List of Figures
Figure 1. Delivery System for Inhaled Nitric Oxide Therapy Picture
Figure 2. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value Market Share by Type in 2022
Figure 4. With Gas Cylinders Examples
Figure 5. Without Gas Cylinders Examples
Figure 6. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity (2018-2029) & (Units)
Figure 14. Global Delivery System for Inhaled Nitric Oxide Therapy Average Price (2018-2029) & (K US$/Unit)
Figure 15. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Delivery System for Inhaled Nitric Oxide Therapy by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Delivery System for Inhaled Nitric Oxide Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Delivery System for Inhaled Nitric Oxide Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Delivery System for Inhaled Nitric Oxide Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Delivery System for Inhaled Nitric Oxide Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Delivery System for Inhaled Nitric Oxide Therapy Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Delivery System for Inhaled Nitric Oxide Therapy Average Price by Type (2018-2029) & (K US$/Unit)
Figure 30. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Delivery System for Inhaled Nitric Oxide Therapy Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Delivery System for Inhaled Nitric Oxide Therapy Average Price by Application (2018-2029) & (K US$/Unit)
Figure 33. North America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Delivery System for Inhaled Nitric Oxide Therapy Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Delivery System for Inhaled Nitric Oxide Therapy Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Delivery System for Inhaled Nitric Oxide Therapy Consumption Value Market Share by Region (2018-2029)
Figure 53. China Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Delivery System for Inhaled Nitric Oxide Therapy Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Delivery System for Inhaled Nitric Oxide Therapy Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Delivery System for Inhaled Nitric Oxide Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Delivery System for Inhaled Nitric Oxide Therapy Market Drivers
Figure 74. Delivery System for Inhaled Nitric Oxide Therapy Market Restraints
Figure 75. Delivery System for Inhaled Nitric Oxide Therapy Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Delivery System for Inhaled Nitric Oxide Therapy in 2022
Figure 78. Manufacturing Process Analysis of Delivery System for Inhaled Nitric Oxide Therapy
Figure 79. Delivery System for Inhaled Nitric Oxide Therapy Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
※参考情報 吸入一酸化窒素療法用投与システムは、主に呼吸器疾患の治療に用いられる医療機器であり、患者に一酸化窒素(NO)を安全かつ効率的に供給するための装置です。この治療法は、特に新生児や成人の肺高血圧症および急性呼吸窮迫症候群(ARDS)に対する効果が期待されています。 本システムの基本的な概念として、一酸化窒素は血管拡張作用を持つガスであり、肺内の血管を拡張することにより、血流を改善し、酸素供給を増加させることができます。これにより、酸素化が向上し、患者の呼吸状態が改善される可能性があります。 吸入一酸化窒素療法の特徴には、非侵襲的であること、迅速な効果を発揮すること、安全性が高いことが挙げられます。この治療法は特に、従来の薬物療法が効果を示さない場合においても有効であり、緊急時に使用されることがあります。また、治療の際に用いる投与システムは、必要な濃度の一酸化窒素を精密に調整できる機能を持ち、患者の状態に応じて適切な投与量を提供します。 投与システムの種類には、ポータブルタイプや固定型、集中型などがあり、使用する環境や患者の状態に応じて選択されます。ポータブルタイプは、移動が可能であるため、在宅療法や病院内移動時に便利です。一方、固定型は病院の特定の部屋で使用されることが多く、安定した供給が行える利点があります。 吸入一酸化窒素療法の用途は広範囲にわたります。例えば、新生児における先天性心疾患の治療では、肺高血圧の管理に利用され、歩行や運動療法を行う患者においても、肺機能の改善を目的として利用されることがあります。また、成人においても、特に重症の肺高血圧症患者に対して有効な治療手段となっています。 関連技術としては、吸入ガスの濃度をモニタリングするセンサー技術、患者の呼吸状態をリアルタイムで監視するための生体情報監視システム、投与システムと連携した電子カルテシステムなどが挙げられます。これらの技術は、治療の安全性と効率を高めるために重要な役割を果たします。また、吸入デバイスがコンパクトであることや、使いやすい設計になっていることも求められます。 さらに、吸入一酸化窒素療法は、その特性から他の治療法と併用されることがあり、例えば、酸素療法や気管支拡張薬と併用することで、更なる効果が期待されます。この多角的アプローチにより、患者に対して包括的な治療を提供することが可能になります。 現在、様々な研究が進められており、吸入一酸化窒素療法の適応範囲を広げるための臨床試験も行われています。将来的には、この療法がより多くの疾患に対して効果を持つことが示されるかもしれません。また、投与システムの技術革新によって、使いやすさや安全性が向上し、患者の生活の質の向上に繋がることが期待されています。 ただし、注意が必要なのは、一酸化窒素は高濃度で使用すると有害な効果を引き起こす可能性があるため、適切な管理が求められます。適正な使用基準やプロトコルを遵守し、安全性を確保することは、どのような医療機器においても最も重要な側面の一つです。 総じて、吸入一酸化窒素療法用投与システムは、特定の呼吸器疾患に対する効果的な治療手段として位置づけられており、技術の進化と共にその役割がますます重要になっていることは間違いありません。今後の研究や技術の発展が、この療法の可能性をさらに広げていくことでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/